Cefpodoxime proxetil and Docetaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefpodoxime proxetil (cefpodoxime proxetil) and Docetaxel (docetaxel). Common drug interactions include febrile bone marrow aplasia among females.

The phase IV clinical study analyzes what interactions people have when they take Cefpodoxime proxetil and Docetaxel. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefpodoxime proxetil?

Cefpodoxime proxetil has active ingredients of cefpodoxime proxetil. eHealthMe is studying from 1,357 Cefpodoxime proxetil users. Check the latest studies of Cefpodoxime proxetil.

What is Docetaxel?

Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.



On Jul, 11, 2026

12 people who take Cefpodoxime proxetil and Docetaxel together, and have interactions are studied.

Cefpodoxime proxetil and Docetaxel drug interactions.

What are the common drug interactions of Cefpodoxime Proxetil and Docetaxel, by gender? *:

female:

  1. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  2. Mucosal inflammation (infection of mucous membrane)
  3. Diastolic dysfunction
  4. Eating disorder
  5. Lymphadenopathy (disease or enlargement of lymph nodes)
  6. Metastases to lung (cancer spreads to lung)
  7. Migraine (headache)
  8. Nocturia (the need to get up in the night to urinate)
  9. Pleural effusion (water on the lungs)
  10. Pruritus (severe itching of the skin)

male:

n/a

What are the common drug interactions of Cefpodoxime Proxetil and Docetaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Capillary leak syndrome (capillary leaks plasma)
  2. Pyrexia (fever)

50-59:

  1. Osteomyelitis (infection of bone)
  2. Sinusitis (inflammation of sinus)

60+:

  1. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  2. Mucosal inflammation (infection of mucous membrane)
  3. Lymphadenopathy (disease or enlargement of lymph nodes)
  4. Metastases to lung (cancer spreads to lung)
  5. Migraine (headache)
  6. Nocturia (the need to get up in the night to urinate)
  7. Pleural effusion (water on the lungs)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Tricuspid valve incompetence (inefficient heart valve)

What are the existing conditions these people have? *

  1. Breast Cancer: 7 people, 58.33%
  2. Pain: 2 people, 16.67%
  3. Itching: 2 people, 16.67%
  4. Gout (uric acid crystals building up in the body): 2 people, 16.67%
  5. Prostate Cancer: 1 person, 8.33%
  6. Fever: 1 person, 8.33%
  7. Abdominal Discomfort: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefpodoxime proxetil and Docetaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefpodoxime proxetil and Docetaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefpodoxime proxetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Docetaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefpodoxime proxetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Docetaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefpodoxime proxetil and docetaxel (the active ingredients of Cefpodoxime proxetil and Docetaxel, respectively), and Cefpodoxime proxetil and Docetaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: